Thermo Fisher Scientific Announce New NGS Technology to Enable Clinical Research in Liquid Biopsy and Immuno-Oncology

Thermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immuno-oncology to complement its comprehensive solutions for clinical research